The optimal ribavirin dose for patients infected with hepatitis C virus genotype 3: should we utilize more?

Hepatology. 2009 Feb;49(2):702-3; author reply 703-4. doi: 10.1002/hep.22732.
No abstract available

Publication types

  • Letter

MeSH terms

  • Dose-Response Relationship, Drug
  • Genotype
  • Hepacivirus / genetics*
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Ribavirin / adverse effects
  • Ribavirin / therapeutic use*

Substances

  • Ribavirin